Synthesis and Characterization of Salinomycin-Loaded High-Density Lipoprotein and Its Effects on Cervical Cancer Cells and Cervical Cancer Stem Cells
Authors:
Open Access
- 1 September 2021
- journal article
- research article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 16, 6367-6382
Abstract
Background: Cervical cancer stem cells (CCSCs), a small part of tumor population, are one of the important reasons for metastasis and recurrence of cervical cancer. Targeting CCSCs may be an effective way to eliminate tumors. Salinomycin (Sal) has been proved to be an effective anticancer drug in many studies, especially for cancer stem cells (CSCs). However, the cytotoxicity of salinomycin limits its further research as an anticancer drug. High-density lipoprotein (HDL) nanoparticles are an excellent drug carrier, which can reduce the toxicity of Sal, have a certain targeting effect and improve the clinical benefit of Sal. Methods: Salinomycin-loaded high-density lipoprotein (S-HDL) was synthesized and characterized by various analytical techniques. CD44highCD24low CCSCs were isolated from HeLa cells by magnetic separation. The uptake of HDL nanoparticles was observed by laser confocal microscopy, and the effect of S-HDL on the proliferation of CCCs and CCSCs was detected by cell viability analysis. Genome-wide analysis was used to analyze the effects of S-HDL on the biological processes of CCCs and then cell apoptosis, cell cycle and cell migration were selected for verification. Results: S-HDL had a particle size of 38.98 ± 1.78 nm and an encapsulation efficiency of 50.73 ± 4.29%. Cell uptake analysis showed that HDL nanoparticles could enhance the drug uptake of CCCs and CCSCs and may target CCCs and CCSCs. In cell viability analysis, CCCs and CCSCs showed high sensitivity to S-HDL. S-HDL can more efficiently prevent CCSCs from developing tumorspheres than Sal in tumorsphere formation study. S-HDL had stronger ability to induce cell cycle arrest, promote cell apoptosis and inhibit cell migration compared with free Sal, which was consistent with the results of Genome Wide analysis. Conclusion: S-HDL can effectively target and eliminate CCCs and CCSCs, which is a potential drug for the treatment of cervical cancer.Keywords
This publication has 60 references indexed in Scilit:
- Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring AmbiguityJournal of Immunology Research, 2012
- Low Density Lipoprotein Receptor-Related Protein 1 Dependent Endosomal Trapping and Recycling of Apolipoprotein EPLOS ONE, 2012
- Apoptosis in cancer: from pathogenesis to treatmentJournal of Experimental & Clinical Cancer Research, 2011
- Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal abilityCancer Gene Therapy, 2011
- High density lipoprotein: it's not just about lipid transport anymoreTrends in Endocrinology & Metabolism, 2011
- A phospholipid–apolipoprotein A-I nanoparticle containing amphotericin B as a drug delivery platform with cell membrane protective propertiesInternational Journal of Pharmaceutics, 2010
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput ScreeningCell, 2009
- LDL Receptor-Related Protein 1: Unique Tissue-Specific Functions Revealed by Selective Gene Knockout StudiesPhysiological Reviews, 2008
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human TumorsCancer Research, 2008
- LRP-1 Silencing Prevents Malignant Cell Invasion despite Increased Pericellular Proteolytic ActivitiesMolecular and Cellular Biology, 2008